3 Year Absolute Returns
70.20% ↑
NAV (₹) on 02 Apr 2026
26.94
1 Day NAV Change
-1.13%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 82.13 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 67.77% |
| Hospitals & Medical Services | 23.76% |
| Treps/Reverse Repo | 3.90% |
| Chemicals - Others | 3.14% |
| Chemicals - Organic - Benzene Based | 1.57% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 11.09% | ₹ 9.11 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.93% | ₹ 5.69 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.87% | ₹ 5.64 | Hospitals & Medical Services |
| Fortis Healthcare Ltd. | 4.94% | ₹ 4.06 | Hospitals & Medical Services |
| Divi's Laboratories Ltd. | 4.81% | ₹ 3.95 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.65% | ₹ 3.82 | Pharmaceuticals |
| Piramal Pharma Ltd. | 4.30% | ₹ 3.53 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 4.04% | ₹ 3.32 | Pharmaceuticals |
| Treps | 3.90% | ₹ 3.20 | Others |
| Onesource Specialty Pharma Ltd. | 3.63% | ₹ 2.98 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 3.44% | ₹ 2.82 | Pharmaceuticals |
| Cipla Ltd. | 3.21% | ₹ 2.64 | Pharmaceuticals |
| Navin Fluorine International Ltd. | 3.14% | ₹ 2.58 | Chemicals - Others |
| Abbott India Ltd. | 3.13% | ₹ 2.57 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.12% | ₹ 2.56 | Pharmaceuticals |
| Glenmark Pharmaceuticals Ltd. | 3.12% | ₹ 2.56 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 3.09% | ₹ 2.54 | Pharmaceuticals |
| Concord Biotech Ltd. | 3.05% | ₹ 2.51 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 2.74% | ₹ 2.25 | Hospitals & Medical Services |
| Artemis Medicare Services Ltd. | 2.73% | ₹ 2.24 | Hospitals & Medical Services |
| Mankind Pharma Ltd. | 2.35% | ₹ 1.93 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.23% | ₹ 1.83 | Hospitals & Medical Services |
| Dr Agarwal's Health Care Ltd. | 2.18% | ₹ 1.79 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 2.16% | ₹ 1.78 | Pharmaceuticals |
| Global Health Ltd. | 2.07% | ₹ 1.70 | Hospitals & Medical Services |
| Acutaas Chemicals Ltd. | 1.65% | ₹ 1.36 | Pharmaceuticals |
| Vinati Organics Ltd. | 1.57% | ₹ 1.29 | Chemicals - Organic - Benzene Based |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -6.95% | -3.58% | 5.96% | 19.40% |
| Category returns | -7.38% | 1.10% | 4.40% | 20.04% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
Axis Quant Fund
Diversified
Regular
|
₹14.17 | -3.21% | 33.05% | 0.00% | ₹882 | 2.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹110.58 | -6.78% | 32.14% | 68.19% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹183.63 | -6.78% | 32.14% | 68.18% | ₹4,273 | 1.92% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
HDFC Banking & Financial Services Fund - Direct Plan
Sector
Direct
|
₹14.90 | 4.00% | 31.81% | 0.00% | ₹4,510 | 0.80% |
Very High
|
|
DSP Quant Fund - Direct Plan
Largecap
Direct
|
₹20.71 | -0.11% | 31.80% | 44.78% | ₹838 | 0.55% |
Very High
|
|
HSBC Infrastructure Fund
Sector
Regular
|
₹31.33 | -7.57% | 31.57% | 70.85% | ₹2,300 | 2.06% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹20.11 | 0.32% | 33.04% | 27.02% | ₹518 | 1.41% |
Very High
|
|
LIC MF Aggressive Hybrid Fund - Direct Plan
Hybrid
Direct
|
₹20.11 | 0.32% | 33.04% | 27.02% | ₹518 | 1.41% |
Very High
|
|
LIC MF Large Cap Fund - Direct Plan
Diversified
Direct
|
₹56.45 | -3.48% | 32.14% | 53.02% | ₹1,422 | 1.10% |
Very High
|
|
LIC MF Large Cap Fund - Direct Plan
Diversified
Direct
|
₹35.54 | -3.49% | 32.11% | 46.12% | ₹1,422 | 1.10% |
Very High
|
|
LIC MF Large Cap Fund - Direct Plan
Diversified
Direct
|
₹35.54 | -3.49% | 32.11% | 46.12% | ₹1,422 | 1.10% |
Very High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹30.59 | 3.64% | 31.55% | 44.85% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹20.66 | 3.63% | 31.49% | 35.27% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹20.66 | 3.63% | 31.49% | 35.27% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹17.04 | 3.63% | 31.48% | 33.38% | ₹36 | 1.34% |
Moderately High
|
|
LIC MF Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹17.04 | 3.63% | 31.48% | 33.38% | ₹36 | 1.34% |
Moderately High
|
What is the current NAV of LIC MF Healthcare Fund Regular Growth?
What is the fund size (AUM) of LIC MF Healthcare Fund Regular Growth?
What are the historical returns of LIC MF Healthcare Fund Regular Growth?
What is the risk level of LIC MF Healthcare Fund Regular Growth?
What is the minimum investment amount for LIC MF Healthcare Fund Regular Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article